William Walsh
@Kingdon Capital Management, L.l.c.
Latest period2024 - Q3ReportedManaged Assets$901.811MTotal holdings76
Assets growth rate-3.33%Assets growth rate (2-Q avg)-0.73%Continuous growth in asset value0 quarters
Portfolio positions
This chart displays the top 10 holdings in Kingdon Capital Management, L.l.c.'s 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 76 positions.
Assets under management
The assets under management (AUM) of Kingdon Capital Management, L.l.c. over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 901.811M in assets, with a quarterly growth rate of -3.33% and a 2-quarter average growth rate of -0.73%. The portfolio is managed by William Walsh, and others.
Portfolio holdings
Investment | Portfolio % | Reported Value | Recent Activity |
---|---|---|---|
SPYSpdr S&p 500 Etf Tr
| 9.55% | $86.064M↓ Put 150,000 shares@ $573.76 avg price | New Position |
XLFSelect Sector Spdr Tr
| 3.77% | $33.99M↓ Put 750,000 shares@ $45.32 avg price | Decreased -6.25% |
INSMInsmed Inc
| 3.24% | $29.2M 400,000 shares@ $73.0 avg price | Decreased -40.54% |
VSTVistra Corp
| 3.16% | $28.45M 240,000 shares@ $118.54 avg price | Increased 500% |
AMDAdvanced Micro Devices Inc
| 3.14% | $28.304M↓ Put 172,500 shares@ $164.08 avg price | Increased 50% |
THCTenet Healthcare Corp
| 3.07% | $27.626M 166,222 shares@ $166.2 avg price | Increased 20.15% |
TNDMTandem Diabetes Care Inc
| 2.5% | $22.477M 530,000 shares@ $42.41 avg price | Increased 43.64% |
PRAXPraxis Precision Medicines I
| 2.35% | $21.175M 368,000 shares@ $57.54 avg price | Decreased -11.32% |
SNDXSyndax Pharmaceuticals Inc
| 2.14% | $19.25M 1M shares@ $19.25 avg price | Increased 11.74% |
MMM3m Co
| 2.13% | $19.138M 140,000 shares@ $136.7 avg price | Increased 27.28% |